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Abstract
Background and Aims: Previous studies have investigated the association between ethnicity and processes of care and
intermediate outcomes of diabetes, but there are limited population-based studies available. The aim of this study was to
use population-based data to investigate the relationships between ethnicity and glycaemic control in men and women
with diabetes mellitus living in Scotland
Methods: We used a 2008 extract from the population-based national electronic diabetes database of Scotland. The
association between ethnicity with mean glycaemic control in type 2 diabetes mellitus was examined in a retrospective
cohort study, including adjustment for a number of variables including age, sex, socioeconomic status, body mass index
(BMI), prescribed treatment and duration of diabetes.
Results: Complete data for analyses were available for 56,333 White Scottish adults, 2,535 Pakistanis, 857 Indians, 427
Chinese and 223 African-Caribbeans. All other ethnic groups had significantly (p,0.05) greater proportions of people with
suboptimal glycaemic control (HbA1c .58 mmol/mol, 7.5%) compared to the White Scottish group, despite generally
younger mean age and lower BMI. Fully adjusted odds ratios for suboptimal glycaemic control were significantly higher
among Pakistanis and Indians (1.85, 95% CI: 1.68–2.04, and 1.62,95% CI: 1.38–1.89) respectively.
Conclusions: Pakistanis and Indians with type 2 diabetes mellitus were more likely to have suboptimal glycaemic control
than the white Scottish population. Further research on health services and self-management are needed to understand the
association between ethnicity and glycaemic control to address ethnic disparities in glycaemic control.
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Introduction
Worldwide the prevalence of diabetes mellitus (DM) is
increasing, with increases expected to be greater than previously
projected [1,2], predominantly due to the growing incidence of
type 2 diabetes mellitus (type 2 DM) [3]. Primary care data from
the UK indicate that the prevalence of DM was 4.26% in 2010,
with the prevalence in Scotland estimated at 4.6% [4]. Scotland
has an established minority ethnic population, representing an
estimated 2% of Scotland’s population in 2001 [5]. Although 2011
census data by ethnicity are not yet available it is anticipated that
this proportion has increased as it has in the rest of the UK. The
largest minority ethnic group within Scotland are South Asians -
people of Indian, Pakistani, Bangladeshi and Sri Lankan origin,
making up 55% of Scotland’s minority ethnic population; with
people of Chinese origin making up around 17% of Scotland’s
minority ethnic population in 2001.
It is recognized that ethnicity influences risk of DM (specifically
type 2 DM), globally and within the UK [1,6]. The prevalence of
type 2 DM in migrant South Asians living in the UK and USA is
up to five times higher than that of their respective indigenous
populations [6]. Further, the age of onset of type 2 DM in South
Asians appears to be around 10 years earlier and occurs at a lower
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body mass index (BMI) than among populations of European
ancestry [7].
Recent data on disease management and natural history of DM
in minority ethnic groups, in particular South Asians with type 2
DM in the UK indicate persisting differences [8], related to
suboptimal processes of care and differences in intermediate
outcomes [7–11,11,12]. One study showed that South Asians had
greater mean deterioration in haemoglobin A1c (HbA1c) than
Europeans after 5-years of follow-up [7]. Another study showed
that from 2004-9 whilst the proportion of patients with HbA1c
,58 mmol/mol, (,7.5%) increased over time in white Europe-
ans, South Asians and African-Caribbeans living in London, only
48% of South Asians had optimal control (HbA1c ,58 mmol/
mol, ,7.5%) compared to 56% of white Europeans [12]. Another
study showed that although South Asians with type 2 DM were
1.11 times (95% CI 1.06, 1.16) more likely to have a structured
review, their HbA1c levels were 1.03 times higher (95% CI 1.00,
1.06) and retinopathy was 1.36 times more common (95% CI
1.03, 1.78) than the non-South Asians [8]. Finally despite
introduction of a pay for performance incentive in U.K. primary
care being associated with improvements in the intermediate
outcomes of diabetes care for all ethnic groups, between 2000 and
2005 the magnitude of improvement relative to predicted
improvement was higher for white Europeans compared to blacks
or South Asians living in London.
The majority of large-scale published UK data on ethnicity and
diabetes focuses on South Asians with DM living in England, with
little data from elsewhere in the UK. Scotland has developed and
maintained a national electronic dataset for people with diagnosed
diabetes that covers approximately 99.5% of the population of 5
million people that is used for clinical care and includes data on
potential confounding factors [13]. The aim of this study was to
use these population-based data to investigate the relationships
between ethnicity and glycaemic control in men and women with
type 2 DM living in Scotland, with and without adjustment for
potential confounding factors.
Methods
Study population and data extraction
Population-based data are available for people with diagnosed
diabetes in Scotland from the Scottish Care Information–Diabetes
Collaboration (SCI-DC) dataset [13]. Briefly, the dataset has
Figure 1. Flow chart showing inclusion and exclusion of cases
for analysis.
doi:10.1371/journal.pone.0083292.g001
Figure 2. Proportion of people with Type 2 diabetes in Scotland with mean of all recorded HbA1c measurements .58 mmol/mol
(7.5%) by ethnicity.
doi:10.1371/journal.pone.0083292.g002
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existed at a national level since 2000, contains demographic and
clinical data relevant to diabetes care that is updated on a daily
basis from approximately 995 of the 1,000 GP practices in and
secondary care databases across Scotland. Further details of the
dataset are available from previous papers [13,14]. People with
diabetes are asked to identify their ethnic group from a standard
list used in the 2001 Census in Scotland
For the present retrospective cohort study, anonymised data
were extracted in May 2008. The dataset initially contained
records of 198,622 patients with diabetes. This analysis included
people of White Scottish, Indian, Pakistani, Chinese and African-
Caribbean ethnic groups. People of Bangladeshi origin were
excluded due to small numbers. Optimal glycaemic control among
people with diabetes relevant to the period of analysis was
considered as an HbA1c ,58 mmol/mol (7.5%) [15], using the
mean of all HbA1c results available for each patient up to May
2008 in the database. Socio-economic status (SES) categorised in
to fifths, with the lowest fifth representing the most affluent, and
highest fifth representing the most deprived group, was assigned
using an area-based measure based on postcode of residence and
the Scottish Index of Multiple Deprivation 2006 score (see http://
www.scotland.gov.uk/Topics/Statistics/SIMD for more informa-
tion).
The study population was determined by excluding subjects
who had implausible data, a diagnosis of diabetes other than type
2 DM and incomplete data (Figure 1). Type of diabetes was
established using an algorithm that included clinical record of type
of diabetes, age at onset and use of insulin/oral hypoglycaemic
Table 1. Comparison of demographic and clinical variables among ethnic groups with Type 2 DM living in Scotland (n = 56713).
Ethnic groups, n (%)
Variable White Scottish African-Caribbean Chinese Indian Pakistani
Gendera
Males (n = 30,621) 28,461 (53.8) 116 (59.2) 195 (49.4) 498 (62.2) 1,351 (55.4)
Females (n = 26,092) 24,423 (46.2) 80 (40.8) 200 (50.6) 303 (37.8) 1,086 (44.6)
Age at diagnosisb
#30 (n = 141) 105 (0.2) 3 (1.5) 4 (1.0) 8 (1.0) 21 (0.9)
31–50 (n = 6,124) 5,145 (9.7) 65 (33.1) 60 (15.2) 195 (24.3) 659 (27.1)
51–70 (n = 28,125) 26,043 (49.3) 101 (51.6) 204 (51.6) 426 (53.2) 1,351 (55.4)
.70 (n = 22,323) 21,591 (40.8) 27 (13.8) 127 (32.1) 172 (21.5) 406 (16.7)
SES
1 (most affluent) (n = 9,041) 8,074 (15.3) 31 (15.8) 101 (25.6) 261 (32.6) 574 (23.6)
2 (n = 9,620) 8,905 (16.8) 21 (10.7) 76 (19.2) 179 (22.3) 439 (18.0)
3 (n = 10,325) 9,845 (18.6) 16 (8.2) 43 (10.9) 99 (12.4) 322 (13.2)
4 (n = 13,124) 12,202 (23.1) 37 (18.9) 72 (18.2) 140 (17.5) 673 (27.6)
5 (most deprived) (n = 14,603) 13,858 (26.2) 91 (46.4) 103 (26.1) 122 (15.2) 429 (17.6)
Average of all BMI values (kg/m2)
,18.5 (n = 112) 103 (0.2) 0 (0.0) 1 (0.3) 2 (0.2) 6 (0.2)
18.5–24.99 (n = 6,445) 5,664 (10.7) 31 (15.8) 158 (40.0) 199 (24.8) 393 (16.1))
25–29.99 (n = 19,964) 18,239 (34.5) 88 (44.9) 176 (44.6) 374 (46.7) 1,087 (44.6)
30–39.99 (n = 25,399) 24,216 (45.8) 62 (31.6) 56 (14.2) 204 (25.5) 861 (35.3)
$40 (n = 4,793) 4,662 (8.8) 15 (7.7) 4 (1.0) 22 (2.7) 90 (3.7)
Duration of diabetes in years
#1 (n = 4,070) 3,778 (7.1) 21 (10.7) 26 (6.6) 68 (8.5) 177 (7.3)
2–5 (n = 14,405) 13,265 (25.10 67 (34.2) 130 (32.9) 241 (30.1) 702 (28.8)
6–10 (n = 20,617) 19,365 (36.6) 65 (33.2) 119 (30.1) 251 (31.3) 817 (33.5)
11–15 (n = 10,296) 9,693 (18.3) 25 (12.8) 68 (17.2) 112 (14.0) 398 (16.3)
.15 (n = 7,325) 6,783 (12.8) 18 (9.2) 52 (13.2) 129 (16.1) 343 (14.1)
Treatment prescribed
Oral (n = 37,266) 34,421 (65.1) 141 (71.9) 306 (77.5) 585 (73.0) 1,813 (74.4)
Insulin (n = 1,084) 1,025 (1.9) 8 (4.1) 4 (1.0) 11 (1.4) 36 (1.5)
Both (n = 10,573) 9,918 (18.8) 33 (16.8) 48 (12.2) 122 (15.2) 452 (18.5)
None/Unrecorded (n = 7,790) 7,520 (14.2) 14 (7.1) 37 (9.4) 83 (10.4) 136 (5.6)
For each minority ethnic group, differences in all variables showed statistically significant association (p,0.01) compared to the Scottish group unless stated otherwise.
ap = 0.13 for comparison between White Scottish and African-Caribbean; p = 0.12 for comparison between White Scottish and Pakistani; p = 0.07 for comparison
between White Scottish and Chinese;
bat time of data extraction;
cmean of all available BMIs for each person.
doi:10.1371/journal.pone.0083292.t001
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agents. In univariate analyses, each potential confounding variable
(sex, age, SES, mean BMI, prescribed treatment, duration) was
individually compared against the exposure (ethnicity) and
outcome (mean glycaemic control following entry into the
database) to investigate possible associations. The association
between ethnicity and glycaemic control was further investigated
using logistic regression. Variables were adjusted for in four stages,
adjusting initially for only age and sex, then adding SES; BMI and
finally all variables. Implausible values for the variables were
excluded before conducting the analyses.
Data analysis
All analyses were performed using categorical variables and chi-
square analysis was performed when comparing data between
ethnic groups (with the exception of HbA1c values which were
presented as continuous variables and Wilcoxon testing was
compared when comparing data between ethnic groups). The age
of the patients in 2008 was converted into a categorical variable,
with four major age-groups formed -#30 years, 31–50 years, 51–
70 years and .70 years. BMI values (mean of all available values
on database) were categorized into five categories according to the
WHO system of classification for people of European extraction-
,18.5 kg/m2 (low), 18.5–24.99 kg/m2 (normal), 25–29.99 kg/m2
(overweight), 30–39.99 kg/m2 (obese) and $40 kg/m2 (morbidly
obese). Treatment related variables were combined into one
variable on the basis of whether the patients were prescribed
insulin or oral drugs, both or no/unrecorded data. Duration of
diabetes (in years) was categorized into 5 groups -#1, 2–5, 6–10,
11–15 and .15 years.HbA1c values were converted into binary
variables, using the overall mean of all HbA1c measurements
available for each patient and the most recently measured HbA1c
value. In addition to the ,58 mmol/mol (7.5%) cut-off, further
analyses were performed with data categorized using 53 mmol/
mol (7%) as a cut-off to define optimal glycaemic control.
All analyses were conducted using SPSS 17. Regression analyses
were conducted using the backward stepwise method of inclusion/
exclusion of variables in the model. The level for inclusion of the
adjusted variables was specified as p#0.05. For each variable, the
reference category was the one with the largest proportion of
people and all other categories were compared against this group.
The association was summarized as p values, odds ratio (OR) and
adjusted odds ratio (AOR) with 95% CI.
Ethical approval
Approval to generate the pseudonymised research dataset
without requiring individual patient consent was obtained from
the "Scotland A" multi-centre research ethics committee, Caldicott
guardians and the Privacy Advisory Committee of NHS National
Services Scotland.
Results
Demographic and clinical data
Data for people with implausible/missing values for HbA1c
were excluded from the analyses (n = 7,375) as shown in Figure 1.
Of the 191,247 people with plausible HbA1c values, 62,809 had
type 2 diabetes and ethnicity data recorded. From this cohort,
60,375 people from one of the five ethnicities described above
were used for analysis, of which 93.3% (56,333 people) were
classed as White Scottish. Of the minority ethnic populations, the
largest group was Pakistani, with 4.2% (2,535 people), and the
smallest ethnic group was African-Caribbean with 0.4% (223
people). Collectively, South Asians (Indians and Pakistanis)
represented 5.6% (3,392 people) of the study population.
Characteristics of people with missing/implausible data were
similar to those included in the analyses (data available on request).
The median HbA1c for each ethnic group (calculated by taking
the median value of all the median values for each person for the
respective ethnic group) were as follows: White Scottish
255 mmol/mol (Interquartile range [IQR]: 49–66 mmol/mol),
African-Carribbean 260 mmol/mol (IQR: 51–73 mmol/mol),
Chinese 254 mmol/mol (IQR: 50–65 mmol/mol), Indian
260 mmol/mol (IQR: 51–73 mmol/mol) and Pakistani
262 mmol/mol (IQR: 54–76 mmol/mol). The difference in
median HbA1c between each ethnic group and the White Scottish
was significant for the African-Caribbean, Indian and Pakistani
comparisons (p = 0.043, p,0.001 and p,0.001 respectively).
Table 2. Proportion of people with Type 2 DM in Scotland
having optimal glycaemic control (mean HbA1c cut-off
58 mmol/mol, 7.5%) for demographic and clinical variables
(n = 56713).
Variables Optimal glycaemic control, n (%)
Gender
Males (n = 30,621) 15,622 (51.0)
Females (n = 26,092) 13,761 (52.7)
Age (years)
#30 (n = 141) 49 (34.8)
31–50 (n = 6,124) 2,288 (37.4)
51–70 (n = 28,125) 13,437 (47.8)
.70 (n = 22,323) 13,609 (61.0)
Mean BMI (kg/m2)
,18.5 (n = 112) 76 (67.9)
18.5–24.99 (n = 6,445) 3,711(57.6)
25–29.99 (n = 19,964) 10,942 (54.8)
30–39.99 (n = 25,399) 12,533 (49.3)
$40 (n = 4,793) 2,121 (44.3)
Treatment prescribed
Oral (n = 37,266) 20,129 (54.0)
Insulin (n = 1,084) 315 (29.1)
Both (n = 10,573) 1,602 (15.2)
None/Unrecorded (n = 7,790) 7,337 (94.2)
Socioeconomic status (SIMD
quintiles)
1 (most affluent) (n = 9,041) 4975 (55.0)
2 (n = 9,620) 5,199 (54.0)
3 (n = 10,325) 5,400 (52.3)
4 (n = 13,124) 6,794 (51.8)
5 (most deprived) (n = 14,603) 7,015 (48.0)
Duration of diabetes
#1 (n = 4,070) 2,350 (57.7)
2–5 (n = 14,405) 8,735 (60.6)
6–10 (n = 20,617) 11,184 (54.2)
11–15 (n = 10,296) 4,484 (43.6)
.15 (n = 7,325) 2,630 (35.9)
All associations between each variable and proportion of optimal mean
glycaemic control was statistically significant (p,0.001)
doi:10.1371/journal.pone.0083292.t002
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All non-white ethnic groups except for the Chinese had
significantly greater (p,0.05) proportions of people with subop-
timal glycaemic control compared to the White Scottish group
regardless of whether mean or recent measures were used for the
definition. More than half the people in each minority ethnic
group had mean glycaemic control .58 mmol/mol (7.5%), with
the exception of the Chinese group, of which only 46% had
HbA1c .58 mmol/mol (7.5%) (Figure 2). Pakistanis had the
highest proportion with suboptimal control.
The characteristics of the study population by ethnicity are
shown in Table 1. The mean age of the people included in this
analysis (at the time of data extraction) was 66.1 years (standard
deviation 12.0 years). Among the South Asians and African-
Caribbeans, there were greater proportions of people in the 31–50
years age group relative to the white Scottish group. As expected
from patterns observed in the general population, distribution of
socio-economic status differed by ethnic group: almost a third of
the Indians were in the most affluent fifth while the African-
Caribbean group had the largest proportion of any ethnic group
identified as the most deprived. There were higher proportions of
men than women in all ethnic groups, with the exception of the
Chinese. Whilst the largest proportion of White Scottish people
was in the 30.0–30.99 kg/m2 BMI category, in all the other ethnic
groups, the most prevalent BMI group was 25–29.99 kg/m2.
The largest proportions of White Scottish and Pakistanis within
the duration categories had type 2 diabetes for 6–10 years;
whereas in the other groups the most common duration was 2–5
years. People from the four minority ethnic groups were more
likely to be on oral hypoglycaemic agents compared to the White
Scottish group.
Glycaemic control
Table 2 summarises the proportion of people with optimal
glycaemic control (,58 mmol/mol, 7.5% cut-off) for the variables
under analysis. Males tended to have poorer control than females
and younger people tended to have poorer control than the
elderly. Similarly, the proportion of people with optimal glycaemic
control decreased as BMI increased. Increasing deprivation was
associated with decreasing proportion of people with optimal
glycaemic control. As expected, measures of disease progression
including treatment and duration of diabetes were associated with
glycaemic control with a more marked association between
treatment than duration of diabetes. Sensitivity analyses demon-
strated that these associations were similar for mean HbA1c and
most recent HbA1c values and when using a,53 mmol/mol (7%)
cut-off to categorise glycaemic control.
Univariate and multivariate analyses of glycaemic control
Table 3 compares the odds ratios (ORs) for poor glycaemic
control between the White Scottish group (reference group) and
other ethnic groups. The crude ORs of having suboptimal
glycaemic control compared to the White Scottish group were
significantly higher in all the other ethnic groups except for the
Chinese. Adjustment for age and sex attenuated the ORs in all
ethnic groups, with the OR only remaining significant in the
Indians and Pakistanis. After adjusting for potential confounding
variables (age, gender, SES, BMI, treatment prescribed, and
duration) as identified using backward stepwise variable
selection in the sub-group of people for whom these data were
available, statistically significant increased odds of suboptimal
glycaemic control persisted in Pakistanis (OR 1.85, 95% CI 1.68–
2.04) and Indians (1.62, 95% CI 1.38–1.89). The changes in point
estimates in the different models reflect the younger age and lower
BMI of ethnic minority groups compared to the white Scottish
group
Discussion
The SCI-DC dataset allowed us to address different factors
affecting glycaemic control in patients with type 2 DM across
Scotland based on ethnicity using data collected since the
introduction of the Quality Outcomes Framework in 2004 which
may have been expected to reduce inequalities in glycaemic
control. The other novel aspects of this work included separation
of data for Indian and Pakistani populations (unlike conventional
aggregation, perhaps also with Bangladeshis and Sri Lankans) in a
South Asian group and presentation of data for African-Caribbean
and Chinese populations with diabetes in Scotland for the first
time. This separation is important since clear difference in CVD
risk have been found between Indians and Pakistanis as
demonstrated in QRISK2 risk calculator [16]. Distribution of
age, sex and SES differed by ethnicity and were associated with
differences in HbA1c suggesting that they may confound the
association between ethnicity and glycaemic control. Our study
showed that Indians and Pakistanis have increased odds of
suboptimal glycaemic control compared to the White Scottish
population after adjustment for confounding variables. We also for
the first time describe data on Chinese and African-Caribbean
people with diabetes living in Scotland. We also demonstrate no
increased prescription of insulin in several minority ethnic groups
(Indian, Pakistani and Chinese) compared to the White Scottish
group, despite these minority ethnic groups having suboptimal
control.
Table 3. Crude and adjusted odds ratios for suboptimal glycaemic control (mean HbA1c .58 mmol/mol, 7.5%) compared to the
white Scottish population (n = 56713).
Ethnic groups, Odds Ratio (95% CI)
White Scottish
(reference) African-Caribbean Chinese Indian Pakistani
Crude 1.00 1.50 (1.13–1.98) 0.97 (0.79–1.18) 1.63 (1.42–1.88) 2.22 (2.04–2.42)
Age and sex adjusted 1.00 1.15 (0.87–1.54) 0.89 (0.73–1.08) 1.36 (1.18–1.58) 1.78 (1.63–1.94)
Age-, sex- and SES-adjusted 1.00 1.12 (0.84–1.5) 0.90 (0.74–1.10) 1.43 (1.24–1.65) 1.83 (1.68–2.00)
Age, sex, SES and BMI adjusted 1.00 1.17 (0.87–1.56) 0.97 (0.79–1.19) 1.51 (1.30–1.74) 1.91 (1.74–2.08)
Fully adjusted 1.00 1.11 (0.81–1.51) 1.01 (0.81–1.26) 1.62 (1.38–1.89) 1.85 (1.69–2.04)
Adjusted variables - sex, age socioeconomic status (SES), BMI, prescribed treatment and duration
doi:10.1371/journal.pone.0083292.t003
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Although we did not aim to describe aetiological factors for type
2 DM, our study also showed that diabetes is accompanied by a
lower BMI in ethnic minority groups when compared to the White
Scottish population. These results, like several previous studies,
support the concept that the association between BMI and type 2
DM risk differs between ethnic groups, with Asians (Chinese and
South Asians) experiencing adverse metabolic effects at lower
BMIs [7,17].
Low socioeconomic status is known to be associated with poor
health outcomes including mortality in type 2 DM in Scotland
[14]. Whilst initial adjustments which included deprivation
attenuated the odds of suboptimal glycaemic control in African-
Caribbeans; in Indians and Pakistanis, the odds attenuated, but
remained significantly higher. Recent data from London also
demonstrated that whilst social deprivation had some influence on
glycaemic control in South Asians and African-Caribbeans,
differences remained after adjustment [12]. Also, our results
suggest that Indians in particular live in less deprived areas
compared to other ethnic groups in Scotland. However measure-
ment of SES in ethnic minority groups is notoriously difficult and
thus these findings should not be over-interpreted [18,19].
It has been recognised that South Asians are less likely to receive
insulin than the indigenous population in the UK, despite having
poorer glycaemic control [9,10], although more recent data may
suggest that insulin usage is increasing in South Asians [12]. A
relatively recent study has shown SAs were more likely to receive
oral hypoglycaemic agents (AOR 2.27; CI, 1.79–2.86) but less
likely to receive insulin (AOR0.54; CI, 0.42–0.69) than the white
group [10]. Reasons for this possibly include increased reluctance
to take up treatment [20], patients’ lack of understanding of their
diagnosis [21] or attitudes shown by health professionals [22].
The dataset used in this study has several strengths. It contained
information for 198,622 people with type 2 diabetes, with
validation of the diagnosis by using criteria to exclude people
with late-onset type 1 diabetes. Even after excluding missing data,
the study population included data for 56,000 people. Further, our
data was nationally representative, making use of electronic data
from over 99% of primary care practices in Scotland, with
previous ethnicity-based studies being regional [8], or from smaller
geographical locations [7,9,10]. While many other studies have
analysed cross-sectional data, the advantage with this dataset was
the availability of multiple HbA1c and BMI values for each
patient, thus providing the opportunity to summarize the overall
mean measures of glycaemic control and BMI for the available
data (although ethnic differences were similar when the most
recent values were used in a sensitivity analysis). This dataset also
gave the opportunity to compare the main South-Asian ethnic
groups individually, rather than collectively against the White
Scottish group. Classification of ethnicity into collective groups,
namely South Asians and Europeans, has been reported as a
weakness by underestimating or overlooking the degree of
difference between South Asian sub- groups [23]. Heterogeneity
within South Asians has been reported for several other
cardiovascular risk factors, including blood pressure and smoking
[23–25] as well as for CVD risk, which seem highest in Pakistanis
[16].
This study is not without its limitations. Some of the statistically
significant differences reported in tables 1 and 2 may have
occurred by chance as a consequence of multiple testing. Ethnicity
was poorly recorded, leading to a large proportion of missing data
and it is possible that the sub-group whose characteristics we have
described is not representative of the whole population of people
with diabetes. Information about country of birth, time since
migration or general practice was not available to us. It is not clear
to what extent higher HbA1c in Pakistanis and Indians reflects
higher HbA1c at diagnosis of diabetes, a faster rise in HbA1c
following diagnosis, under-treatment or poorer compliance or
response to lifestyle interventions or pharmacological treatments,
ethnic differences in prevalence of anaemia and haemoglobinop-
athy and all of these factors may be relevant. This study did not
address differences in treatment between ethnic groups, as data
were only available on recording of prescribed treatment at the
time of data extraction in 2008, with no data available on drug
dosage or treatment duration or validation of these data in this
analysis. Differences in drug treatment may partly explain the
disparities in glycaemic control. Another limitation of this analysis
is that data on ethnicity was only recorded for 38% of the patients
with type 2 DM, although the study population appeared to be
representative of the whole cohort, as described earlier. Unfortu-
nately we did not have the opportunity to use name recognition
software to attempt to assign ethnicity before the pseudonymised
research extract was performed and the approvals we have for use
of the data prevent use of the identifiable data - more recently
there has been an improvement in recording ethnicity data [4],
with 78% of patients having their ethnicity recorded in 2011 [26].
It was not possible to validate the recording of ethnicity or other
variables in the dataset. The absence of a single, uniform standard
for collecting and reporting diabetes-related information and
testing HbA1c is likely to have resulted in differences in the quality
of the data as also the number and the frequency of HbA1c tests
conducted. As we used mean values to summarise glycaemic
control and other risk factors, we were unable to investigate
whether ethnicity is associated with variability of HbA1c and other
factors which has been found to be associated with mortality in
elderly people with diabetes [27]. Finally, the small numbers of
Bangladeshis in this dataset limited our ability to investigate
glycaemic control in this population.
In conclusion, our nationally representative data show that
Indians and, more strikingly, Pakistanis had significantly increased
odds of suboptimal control than the White Scottish population
both before and after adjusting for potential confounders, whereas
proportions with suboptimal glycaemic control were similar to the
Scottish population in Chinese or African-Caribbean groups. The
role of other factors such as treatment-specific responses, physician
to patient communication as way to improve glycaemic control in
South Asians and the association between glycaemic control and
complications of diabetes including hospital admissions are clearly
relevant areas for future research.
Author Contributions
Conceived and designed the experiments: SHW PHN. Performed the
experiments: SHW PHN. Analyzed the data: PHN SHW. Wrote the
paper: PHN NG NS SHW. Revised the manuscript critically for important
intellectual content: PHN NG NS SHW HMC CMF RSL JAM JP SP.
References
1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4–14. S0168-
8227(09)00432-X [pii];10.1016/j.diabres.2009.10.007 [doi].
2. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of
diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:
1047–1053.
Ethnic Differences in Type 2 Diabetes in Scotland
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e83292
3. Gonzalez ELM, Johansson S, Wallander MA, Rodriguez LAG (2009) Trends in
the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol
Community Health 63: 332–336.
4. Scottish Diabetes Survey Monitoring Group (2012) Scottish Diabetes Survey
2010.
5. Scottish Executive (2012) Analysis of Ethnicity in the 2001 Census - Summary
Report.
6. Hall LML, Sattar N, Gill JMR (2008) Risk of metabolic and vascular disease in
South Asians: potential mechanisms for increased insulin resistance. Future
Lipidology 3: 411–424.
7. Mukhopadhyay B, Forouhi NG, Fisher BM, Kesson CM, Sattar N (2006) A
comparison of glycaemic and metabolic control over time among South Asian
and European patients with Type 2 diabetes: results from follow-up in a routine
diabetes clinic. Diabet Med 23: 94–98.
8. Fischbacher CM, Bhopal R, Steiner M, Morris AD, Chalmers J (2009) Is there
equity of service delivery and intermediate outcomes in South Asians with type 2
diabetes? Analysis of DARTS database and summary of UK publications.
J Public Health (Oxf) 31: 239–249. fdp003 [pii];10.1093/pubmed/fdp003 [doi].
9. McElduff P, Edwards R, Burns JA, Young RJ, Heller R, Long B, Jones G, New
JP (2005) Comparison of processes and intermediate outcomes between South
Asian and European patients with diabetes in Blackburn, north-west England.
Diabet Med 22: 1226–1233. DME1614 [pi i ] ;10.1111/j .1464–
5491.2005.01614.x [doi].
10. Verma A, Birger R, Bhatt H, Murray J, Millett C, Saxena S, Banarsee R, Gnani
S, Majeed A (2010) Ethnic disparities in diabetes management: a 10-year
population-based repeated cross-sectional study in UK primary care. J Public
Health (Oxf) 32: 250–258. fdp114 [pii];10.1093/pubmed/fdp114 [doi].
11. Millett C, Netuveli G, Saxena S, Majeed A (2009) Impact of pay for
performance on ethnic disparities in intermediate outcomes for diabetes: a
longitudinal study. Diabetes Care 32: 404–409. dc08-0912 [pii];10.2337/dc08-
0912 [doi].
12. James GD, Baker P, Badrick E, Mathur R, Hull S, Robson J (2012) Ethnic and
social disparity in glycaemic control in type 2 diabetes; cohort study in general
practice 2004-9. J R Soc Med. jrsm.2012.110289 [pii];10.1258/
jrsm.2012.110289 [doi].
13. McKnight JA, Morris AD, Cline D, Peden N, Fischbacher C, Wild S (2008)
Implementing a national quality assurance system for diabetes care: the Scottish
Diabetes Survey 2001–2006. Diabet Med 25: 743–746. DME2453
[pii];10.1111/j.1464–5491.2008.02453.x [doi].
14. Walker JJ, Livingstone SJ, Colhoun HM, Lindsay RS, McKnight JA, Morris
AD, Petrie JR, Philip S, Sattar N, Wild SH (2011) Effect of socioeconomic status
on mortality among people with type 2 diabetes: a study from the Scottish
Diabetes Research Network Epidemiology Group. Diabetes Care 34: 1127–
1132. dc10-1862 [pii];10.2337/dc10-1862 [doi].
15. Scottish Intercollegiate Guidelines Network (SIGN) (2010) Management of
diabetes.
16. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A,
Brindle P (2008) Predicting cardiovascular risk in England and Wales:
prospective derivation and validation of QRISK2. BMJ 336: 1475–1482.
bmj.39609.449676.25 [pii];10.1136/bmj.39609.449676.25 [doi].
17. Razak F, Anand SS, Shannon H, Vuksan V, Davis B, Jacobs R, Teo KK,
McQueen M, Yusuf S (2007) Defining obesity cut points in a multiethnic
population. Circulation 115: 2111–2118.
18. Bhopal R (1997) Is research into ethnicity and health racist, unsound, or
important science? BMJ 314: 1751–1756.
19. Smith GD (2000) Learning to live with complexity: ethnicity, socioeconomic
position, and health in Britain and the United States. Am J Public Health 90:
1694–1698.
20. Ahmed US, Junaidi B, Ali AW, Akhter O, Salahuddin M, Akhter J (2010)
Barriers in initiating insulin therapy in a South Asian Muslim community.
Diabet Med 27: 169–174. DME2904 [pii];10.1111/j.1464-5491.2009.02904.x
[doi].
21. Choudhury SM, Brophy S, Williams R (2009) Understanding and beliefs of
diabetes in the UK Bangladeshi population. Diabet Med 26: 636–640.
DME2741 [pii];10.1111/j.1464-5491.2009.02741.x [doi].
22. Mir G, Sheikh A (2010) ’Fasting and prayer don’t concern the doctors … they
don’t even know what it is’: communication, decision-making and perceived
social relations of Pakistani Muslim patients with long-term illnesses. Ethn
Health 15: 327–342. 922839101 [pii];10.1080/13557851003624273 [doi].
23. Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, Harland J, Patel
S, Ahmad N, Turner C, Watson B, Kaur D, Kulkarni A, Laker M, Tavridou A
(1999) Heterogeneity of coronary heart disease risk factors in Indian, Pakistani,
Bangladeshi, and European origin populations: cross sectional study. BMJ 319:
215–220.
24. Agyemang C, Bhopal RS (2002) Is the blood pressure of South Asian adults in
the UK higher or lower than that in European white adults? A review of cross-
sectional data. J Hum Hypertens 16: 739–751. 10.1038/sj.jhh.1001488 [doi].
25. Race Equality Foundation (2012) Better Health Briefing 22: Tobacco use among
minority ethnic populations and cessation interventions.
26. Scottish Diabetes Survey Monitoring Group (2013) Scottish Diabetes Survey
2011.
27. Zoppini G, Verlato G, Targher G, Bonora E, Trombetta M, Muggeo M (2008)
Variability of body weight, pulse pressure and glycaemia strongly predict total
mortality in elderly type 2 diabetic patients. The Verona Diabetes Study.
Diabetes Metab Res Rev 24: 624–628. 10.1002/dmrr.897 [doi].
Ethnic Differences in Type 2 Diabetes in Scotland
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e83292
